Available Structures
10 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| 1.9A crystal structure of HLA-G |
Heteromer P16104; P61769; | 98.91 | 1×CO; 2×CL; | |||
| Crystal Structure of LILRB2(LIR2/ILT4/CD85d) complexed with HLA-G |
Heteromer P16104; P61769; Q8N423; | 99.64 | ||||
| Crystal structure of the four Ig-like domains of LILRB1 complexed with HLA-G |
Heteromer P04908; P61769; Q8NHL6; | 98.91 | ||||
| Crystal structure of HLA-G presenting KGPPAALTL peptide |
Heteromer P61769; | 98.91 | 1×CO; 2×CL; | |||
| Crystal structure of disulfide-linked HLA-G dimer |
Heteromer P16104; P61769; | 100.0 | ||||
| Crystal structure of HLA-G presenting KLPAQFYIL peptide |
Heteromer P61769; | 98.9 | 1×CO; | |||
| Structural and functional basis for HLA-G isoform recognition of immune checkpoint receptor LILRBs |
Heteromer P61769; Q8NHL6; Q9BTM1; | 99.61 | 4×IOD; | |||
| The human non-classical major histocompatibility complex molecule HLA-E |
Heteromer P13747; P61769; | 100 | ||||
| Human CD94/NKG2A in complex with HLA-E |
Heteromer P13747; P26715; P61769; Q13241; | 100 | ||||
| Structure of NKG2A/CD94 bound to HLA-E |
Heteromer P13747; P26715; P61769; Q13241; | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7u1r.1.A | monomer | 0.85 | 80.95 | |||
6 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8rcv.1.A | monomer | 0.80 | 78.69 | |||
| Isoform 3 | 8rbu.1.A | monomer | 0.71 | 79.51 | |||
| Isoform 4 | 3kyn.1.A | monomer | 0.75 | 1×LYS; | 83.03 | ||
| Isoform 5 | 8ref.1.A | monomer | 0.86 | 77.99 | |||
| Isoform 6 | 8rcv.1.A | monomer | 0.83 | 79.15 | |||
| Isoform 7 | 7tlt.1.A | monomer | 0.82 | 81.58 | |||